The Latest Breaking News from FDA

Supporters of abortion rights have filed separate lawsuits challenging abortion pill restrictions in North Carolina and West Virginia

Nancy Brier suffered all her life from treatment-resistant depression. Then she heard of ketamine therapy. As a 55-year-old mother who’d never even inhaled helium, she was reticent — but decided she had everything to gain and little to lose

Moves by the Biden administration to expand access to a drug first approved in 2000 have spawned multiple lawsuits.

By almost any measure, the vaccination campaign against SARS-CoV-2, the virus that causes COVID-19, has been a global success.

Toxic metal can be harmful to developing brains. New lead targets are part of a broad FDA imitative to reduce children's exposure to the lowest levels possible.

Money and lobbying help shield lab-developed tests, including prenatal screenings, from heightened federal scrutiny

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

An independent investigation into logging in the Liberian rainforest found illegal operations “on a significant scale,” with multiple missteps or breaches of law by the government agency charged with protecting those forests

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

The virus has not yet fully settled into a pattern of seasonality and may never, experts caution.

Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical company was warned over lapses in contamination control and manufacturing practices.